chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Driving home 18-20 mins post injection, my heart started racing, my hands were shaking, it became hard to breathe, my fingers were tingling and my mouth got very dry. I pulled over and called 911. The paramedics stated my BP was within normal limits of around 140/80. My normal is closer to 90/65. Once symptoms resolved I attempted to drive home. Once again, the same symptoms returned. I pulled over. I then made my way to a safe location and waited for family to come. Since the event I have had times of mild labored breathing while walking. While driving I become very anxious and the feelings of an anxiety attack return. I saw my nurse practitioner 2 days ago who referred to the driving anxiety as a form of PTSD and prescribed Prozac and Xanax. I have not take the Xanax, but have taken two nighttime doses of Prozac. Yesterday, I did not feel as though I had taken medication. My drive to work was uneventful. My drive home involved tightening of the chest, labored breathing and anxiety. This morning I cannot tell if I am feeling the vaccine or Prozac in my system, but I feel off. Swimmy headed, watery mouth, heaviness in my arms and shoulders. I need guidance on taking the 2nd vaccine or if I should seek further medical treatment. I have added a vit B vitamin a day to my regimen since the date of the vaccine.
Member felt slight throat tightness after 15 minute observation.  MD observer provided 25mg benadryl PO.  MD ovserver recommended that the patient go to the ED to be further evaluated.
5 MINUTES AFTER RECEIVING VACCINE PT SAID SHE WAS FEELING SHAKY WITH PALPATATIONS. WE CALLED 911 AT WHICH TIME THE PHARMACIST WAS ADVISED TO ADMINISTER THE EPPY PEN. EMT ASSESSED PT AND ADVISED HER TO GO TO PRIMARY CARE PHYSICIAN
Numbness in hand; Lymph nodes extremely sore; shortness of breath multiple times; Higher heart rate; Inflammation; Pain in neck; Pain in shoulder; Extreme pain in right calf muscle for two days straight; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWA51), via an unspecified route of administration in the left arm on 14Apr2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Medical history included anxiety and asthma. The patient did not have a history of allergies to any food or medications or other products. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Apr2021, the patient experienced numbness in hands, lymph nodes extremely sore, shortness of breath multiple times, higher heart rate, inflammation, pain in neck, pain in shoulder, extreme pain in right calf muscle. It was reported that numbness in hands for one week after vaccine starting one day after injection, lymph nodes extremely sore for one week after, two weeks after vaccine and into a third week after shortness of breath multiple times, along with higher heart rate and she went to doctor and prescribed anxiety medicine along with a steroid treatment since the doctor could tell there was much inflammation, got blood work done twice with borderline high level of d dimer indicating inflammation, pain in neck, pain in shoulder, extreme pain in right calf muscle for two days straight and got a ultrasound done to rule out a blood clot. Also, was given a breathing test to test function of lungs, which was fine. Steroid treatment helped clear inflammation and pain from the vaccine aftermath. She went to a diagnostic centre on 07May2021 to have an ultra sound done on her right calf muscle because of all the pain and no blood clot was found. The patient visited primary care doctor three times along with a specialized testing center for symptoms. Therapeutic measures were taken as a result of events which included treatment with steroid and anxiety medicine. On an unknown date the patient underwent lab tests and procedures which included breathing test and the result was normal, blood work done and the result was borderline high level of d dimer and on 07May2021, the patient underwent ultrasound scan for right calf muscle and the result was no blood clot found. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events numbness in hands, lymph nodes extremely sore, shortness of breath multiple times, higher heart rate, inflammation, pain in neck, pain in shoulder, extreme pain in right calf muscle was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
I had a rash appear from the right side of my body up my back which made me go to the ER. It was determined that it was Shingles. I was told to dab Maalox on all of my blisters to dry them up.
received the first dose of Twinrix back back on 8/27/2019 and never came back to finish the series; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 54-year-old male patient who received HAB (Twinrix adult) for prophylaxis.   Previously administered products included Twinrix adult (received 1st dose on 27th August 2019 with batch number 3C422 and expiry date 27th April 2021).   On an unknown date, the patient did not receive the 2nd dose of Twinrix adult. On an unknown date, an unknown time after receiving Twinrix adult, the patient experienced incomplete course of vaccination (Verbatim: received the first dose of Twinrix back back on 8/27/2019 and never came back to finish the series). The outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 26-JUN-2023 The registered pharmacist reported the patient received the first dose of Twinrix and never came back to finish the series. The pharmacist inquired did the patient need to restart the Twinrix vaccine series.  The reporter did not consent to follow-up. Till the time of reporting the patient did not receive the 2nd dose of Twinrix adult, which led to incomplete course of vaccination.
AFTER LAST IM VACCINE, CHILD STARTED SCREAMING, AND ERYTHEMA OF THE FACE AND LOWER EXTERMITIES OCCURRED WHICH PROGRESSED TO OTHER PARTS OF THE BODY - ARMS, CHEST AND BACK. NO FRANK URTICARIA JUST A GENERALIZED BLANCHING ERYTHEMA. NO WHEEZING, NO SWELLING OF THE EYES OR LIPS NOTED. BLOW- BY O2 WAS STARTED AND BENADRYL 7.5 MG IM GIVEN WHILE 911 WAS ACTIVATED. THE ERYTHEMA SUBSIDED GRADUALLY AFTER bENADRYL. PATIENT WAS TAKEN TO ER BY AMBULANCE.
Headache, Myalgia, Fever, chills, temp 100.9 Narrative:
Had stronger symptoms beginning after the second shot. heart palpitations, some shortness of breath, muscle tremors in arms and legs, tachycardia, anxiety, some pain just below ribs, back pain,
On 11/13/00, a father into Public Health and reports 2 days after shots, The patient had a fever of about 102. They talked to NP at the clinic and used cold packs on her arm and Tylenol. Then the fever left.
No adverse effects reported; Multiple patients were vaccinated with improperly stored VAQTA; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history, as well as concomitant medications, were not reported.  On 13-JUN-2019, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) 25/0.5 (units not provided), lot # R018935, expiration date 05-SEP-2019, for prophylaxis (dose, route, anatomical site and frequency were not reported). The reporter stated that the vaccine had a temperature excursion of 34.2 F for 4 hours and 54 minutes, which was detected by a data logger. The vaccine had no previous temperature excursion and there were no adverse effects reported.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-1907USA001174: US-009507513-1907USA004852: US-009507513-1907USA004853: US-009507513-1907USA004854: US-009507513-1907USA004855: US-009507513-1907USA004856: US-009507513-1907USA004857: US-009507513-1907USA004858: US-009507513-1907USA004859: US-009507513-1907USA004860: US-009507513-1907USA004861: US-009507513-1907USA004862: US-009507513-1907USA004863: US-009507513-1907USA004864: US-009507513-1907USA004865: US-009507513-1907USA004866: US-009507513-1907USA004867: US-009507513-1907USA004868: US-009507513-1907USA004869: US-009507513-1907USA004870: US-009507513-1907USA004871: US-009507513-1907USA004872: US-009507513-1907USA004873: US-009507513-1907USA004874: US-009507513-1907USA004876: US-009507513-1907USA004877: US-009507513-1907USA004878: US-009507513-1907USA004879: US-009507513-1907USA004880: US-009507513-1907USA004881: US-009507513-1907USA004882: US-009507513-1907USA004883: US-009507513-1907USA004884: US-009507513-1907USA004885: US-009507513-1907USA004886: US-009507513-1907USA004887: US-009507513-1907USA004888: US-009507513-1907USA004889: US-009507513-1907USA004890:
Patient required to stay 30 minutes for monitoring due to previous reactions:  tetanus (reported dizziness, no anaphylaxis or treatment needed) and Norco in which anaphylaxis was reported. Patient stated she has had flu shots and pneumonia vaccinations in past. Approximately 15 - 20 minutes into monitoring patient reported headache and feelings of throat spasm. She took diphenhydramine that she had with her because of her past experience with anaphylaxis. At the end of the 30 minute monitoring period she said the throat spasm was not any worse and did not report any new symptoms, but an ambulance was contacted to take her to the local ER as a precaution. According to patient, she was monitored in the ER and given iv medications and sent home later in the afternoon.  The patient stated she believes she was given a steroid medication and anti-nausea medication to fill at an outpatient pharmacy (unknown, uses other pharmacy).
Flu like symptoms for approximately 24 hours.  Headache, muscle aches.  Course of action Tylenol.
This case was reported by a healthcare professional and described the occurrence of injection site joint swelling in a 42-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). Concurrent medications included SYNTHROID and Losartan. On 9 October 2012 at 10:00 the subject received unspecified dose of FLULAVAL (.5 ml, unknown, right arm). On 10 October 2012, 1 day after vaccination with FLULAVAL, the subject experienced injection site joint swelling and injection site joint pain. The subject received the same vaccine last year and was fine. She received the vaccine on 09 October 2012 and reported local joint swelling and joint pain. The subject was treated with TYLENOL, two tablets on 10 October 2012. The healthcare professional considered the events were clinically significant (or requiring intervention). At the time of reporting the injection site joint swelling and injection site joint pain were unresolved.
accidental overdose is reported in a pt receiving fluogen; pt has hx of alzheimer's disease; This is 1 of 30 cases reported from this site; No adverse effects noted;
Breakthrough case. Started having a sore throat. Took a home COVID-19 test and it was positive. Went to Dr office and Rapid Test was positive as well. Was prescribed Paxlovid. 10 days later home COVID-19 test was negative.
cold; Fatigue; Chills; Fever; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A 69-year-old female patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL8982) at left arm, via an unspecified route of administration on 21Jan2021 13:30 at single dose for covid-19 immunisation. Medical history was none. Prior vaccinations (within 4 weeks) were none. Family Medical History Relevant to adverse events was none. There were no concomitant medications. The patient experienced chills on 22Jan2021, fever on 22Jan2021, fatigue on 23Jan2021, cold on an unspecified date. The patient received no treatments. The patient had the Pfizer shot last Thursday (21Jan2021) and afterward had chills and fever. Now she was so tired. The events did not require a visit to Emergency Room or Physician Office. The patient's weight was 145-150 lbs. The outcome of events chills and fever was recovered on 23Jan2021; of fatigue was not recovered; of cold was unknown.
Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Headache-Mild
Nasal congestion and cough 1-2 days after vaccine x 3 - Dx URI/ Sinusitis, Treatment Z-Pak.
Information has been received from a physician's assistant (PA), via a company representative, concerning her 17 year old daughter, who on an unknown date was vaccinated with the first dose of Gardasil (Lot # not specified). Concomitant therapy included (VARIVAX) (MSD) and an additional unspecified vaccine. The PA stated that her daughter, "after receiving her first dose of (Gardasil) fainted." At the time of this report, her daughter had recovered (duration and date not specified). The patient sought unspecified medical attention. Additional information has been requested.
Patient returned to clinic with mom.  Red, swollen, upper left arm.  DTAP and IPV were given in left arm.
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 70 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: 19-SEP-2021) dose was not reported, administered on 05-NOV-2021 for prophylactic vaccination. No concomitant medications were reported.  On 05-NOV-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious.
first 24 hours after the vaccine were not too bad. arm was sore. as the 16 hour mark came on, began to feel tired and sore. by the 20 hour mark had enough to climb into bed and was in bed for a couple of days. barely able to move for the body pain, the muscle cramps, the joint pain, sweats and chills. For weeks after I would have night sweats where I would wake up smoking wet.  Even now, a month later I continue to fight joint pain that I did not have before.
6 days post vax, devel hyperesthesias over lt side of face; no paresthesias, numbness, rash, URI or allergy sx; no motor deficits; Also had local rx p/inject arm pain, swelling @ inject site, w/swollen & tender ax lymph node;
Starting 07/20/2022, I had symptoms. I did the at-home COVID-19 test the same day which was positive. I called the clinic that day and they scheduled me for the monoclonal antibody infusion the next day. After this I came home and went to bed early, and upon waking up on 07/22/2022, I felt much better. I have been feeling better progressively since then. I am still experiencing some "brain fog" to this day.
shingles; Information has been received from a lawyer regarding a case in litigation referring to a female patient of unknown age. Information about medical history, concurrent condition and concomitant medication was not reported. On or around 24-JUL-2013, the patient was inoculated with Zoster Vaccine Live (ZOSTAVAX) (strength, dose, route, lot# and expiration date unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving Zoster Vaccine Live (ZOSTAVAX), the patient suffered a bad case of the shingles. As a direct and proximate result of Zoster Vaccine Live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using Zoster Vaccine Live (ZOSTAVAX). The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of Zoster Vaccine Live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of Zoster Vaccine Live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of Zoster Vaccine Live (ZOSTAVAX), the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the event shingles was not recovered. Causality was assessed as related.   The lawyer considered the event shingles to be disability.
Patient described a shingles flare the day after her injection and also described intensification of chronic pain, above and beyond normal pain, for the two days after her vaccination.
UPON INJECTION, THE NEEDLE PENETRATED THE SKIN SLIGHTLY THEN BOUNCED BACK OUT OF THE SKIN BEFORE THE DOSE WAS GIVEN. PT STABLE, NO BLEEDING. PT AGREED ANOTHER TRY. PT RECEIVED 2ND DOSE OF PFIZER IN HIS LEFT ARM.
Received Janssen vaccine on 4/2/21; Moderna on 11/2/21 COVID-19 positive by PCR on  1/5/22 admitted to hospital 1/11-1/14/22 for NSTEMI; Suspected pneumonia in the anterior right upper lobe accounting for consolidative opacities. ID consulted for positive COVID-19 and recommendations included a three day course of remdesivir
Patient felt light-headed and dizzy 15 minutes after receiving the vaccine. She also felt like her hand was shaking. Her forehead and cheeks appeared to be red and flushed. Her symptoms did not improve, she was evaluated by the ID physician and was transferred to the ER.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In 2016, The patient's healthcare provider administered the ZOSTAVAX vaccine to the patient. The patient was inoculated with the ZOSTAVAX, (lot# and route unknown) vaccine to obtain permanent prevention and protection against shingles and zoster-related injuries. In 2016, the patient was treated by her healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages.  Additional information has been requested.
Arm was swollen; tired; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen) and FATIGUE (tired) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M21A, 037F21A, 011M20A and 028L20A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Arm was swollen) and FATIGUE (tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Arm was swollen) and FATIGUE (tired) had resolved.            Patient had no prior health conditions. No concomitant medication were reported.  Patient was tired and arm was swollen for a couple of days.
Started with nausea, diarrhea. Then fever 102, headache, total exhaustion, dizzy, poor balance, sleeplessness, chills. Advil for fevers
1305: developed itching, 25mg Bendaryl given 1315: vomitted, red cheeks 1333: continued nausea, called rapid response 1345: Vitals stable. Cont. nausea but rapid response cleared CG to leave clinic 1400: Developed red arms,  resolved by 0600 10/5/2021
Pt had a febrile seizure after getting Pediarix, Hepatitis A, MMR, Hib and Prevnar 13 vaccines.
Pt recv vax on 2/10/99; 15 min post vax pt exp tearing, dizzy, cool skin, clammy, pale, red-hot flush rash on shoulders/ neck/ face, sleepy; tx=rest, elevated feet, Benadryl
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (kind of a sore spot in her arm/started experiencing a sore spot in her arm where she received) and URTICARIA (started experiencing hives/every day the hives are showing up in different parts of her body) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 025C21A) for COVID-19 vaccination. Patient did not had allergies to medications, food and other products. Patient did not receive other vaccines within 1 month prior to Moderna COVID-19 vaccine. The patient's past medical history included COVID-19. Concomitant products included ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (LO LOESTRIN FE) for an unknown indication. On 30-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 27-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 16-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. In March 2022, the patient experienced URTICARIA (started experiencing hives/every day the hives are showing up in different parts of her body). On 16-Mar-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (kind of a sore spot in her arm/started experiencing a sore spot in her arm where she received). The patient was treated with PREDNISONE for Adverse reaction, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse reaction, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (kind of a sore spot in her arm/started experiencing a sore spot in her arm where she received) and URTICARIA (started experiencing hives/every day the hives are showing up in different parts of her body) had not resolved. It was reported that, within a day or two post vaccination, the patient started experiencing hives. The hives have gotten so bad at this time that patient had to drive back from one city to another so that patient could have it looked by her doctor. The hives have worsened overtime and have spread all over her body including her legs, chest, neck, and face. Every day the hives are showing up in different parts of her body. Some are the size of a quarter, and some are almost the size of a  softball. The patient did not experience a similar event in the past. AE cause patient to seek urgent care.